Ftse Mib
33.067,99
-0,30%
DAX
19.261,75
-0,22%
S&P 500
5.999,82
-0,36%
NASDAQ
19.063,14
-0,59%
Bitcoin
96.803,52
5,25%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Marinus Pharmaceuticals Inc (MRNS) Marinus Pharmaceuticals Inc (MRNS) Notizie

Marinus Pharmaceuticals Inc

MRNS
0,3182
-0,0036 (-1,12%)
Ultimo aggiornamento: 20:47:43
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/11/202414:00EDGAR2Form 8-K - Current report
15/11/202400:39EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
14/11/202421:04EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202418:24EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202415:34EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:05EDGAR2Form 8-K - Current report
12/11/202422:00BWMarinus Pharmaceuticals Provides Business Update and Reports..
02/11/202401:30EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
24/10/202414:05EDGAR2Form 8-K - Current report
24/10/202414:00BWMarinus Pharmaceuticals Announces Topline Results From Phase..
17/10/202413:00BWMarinus Pharmaceuticals Presents Clinical Data From Pivotal..
15/10/202422:00BWMarinus Pharmaceuticals Further Strengthens Intellectual..
09/10/202413:00BWMarinus Pharmaceuticals Announces Podium and Poster..
08/10/202422:04BWMarinus Pharmaceuticals Announces Inducement Grants Under..
02/10/202413:56EDGAR2Form 8-K - Current report
20/9/202414:15EDGAR2Form 8-K - Current report
20/9/202414:00BWMarinus Pharmaceuticals to Highlight Clinical Progress and..
12/9/202414:00BWMarinus Pharmaceuticals Announces Agenda and Speakers for..
10/9/202414:00BWMarinus Pharmaceuticals to Present at the 2024 Cantor Global..
19/8/202414:00BWMarinus Pharmaceuticals to Host Investor and Analyst Day on..
13/8/202414:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202413:09EDGAR2Form 8-K - Current report
13/8/202413:00BWMarinus Pharmaceuticals Provides Business Update and Reports..
07/8/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202411:45PRNUSMarinus Pharmaceuticals, Inc. Class Action: The Gross Law..
30/7/202414:00BWMarinus Pharmaceuticals to Provide Business Update and..
25/7/202411:45PRNUSThe Gross Law Firm Notifies Marinus Pharmaceuticals, Inc...
18/7/202413:00BWMarinus Pharmaceuticals Announces Ganaxolone Approved in..
17/7/202411:45PRNUSMarinus Pharmaceuticals, Inc. Sued for Securities Law..
12/7/202411:45PRNUSShareholders that lost money on Marinus Pharmaceuticals,..
08/7/202422:32EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
03/7/202411:45PRNUSThe Gross Law Firm Reminds Marinus Investors of the Pending..
28/6/202411:45PRNUSMarinus Pharmaceuticals, Inc. Sued for Securities Law..
17/6/202413:01EDGAR2Form 8-K - Current report
17/6/202413:00BWMarinus Pharmaceuticals Announces Topline Results from Phase..
06/6/202422:55EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/6/202422:05EDGAR2Form 8-K - Current report
24/5/202412:35EDGAR2Form 8-K - Current report
17/5/202413:05EDGAR2Form 8-K - Current report
17/5/202413:00BWMarinus Pharmaceuticals Announces Key Business Updates for..
08/5/202413:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202413:05EDGAR2Form 8-K - Current report
08/5/202413:00BWMarinus Pharmaceuticals Provides Business Update and Reports..
02/5/202414:00BWMarinus Pharmaceuticals to Present at the RBC Capital..
01/5/202414:00BWMarinus Pharmaceuticals to Provide Business Update and..
15/4/202413:00BWMarinus Pharmaceuticals Provides Update on the Phase 3 RAISE..
Apertura: 0,3218 Min: 0,3108 Max: 0,324999
Chiusura: 0,3218

La tua Cronologia

NASDAQ
MRNS
Marinus Pharmaceuticals
BIT
UB8LJL
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network